Home page

Structured Cases.
Clinical Insights.
Better Care.

The Physicians Experience Platform (PEP) is designed to advance individualized therapy with cannabis-based medicines. It shares real-world physician experiences through structured case reports, offering clinical insights into anonymised patient cases: such as treated indications, symptoms, dosages, potential side effects, and treatment outcomes. All content is contributed by qualified medical professionals and intended exclusively for healthcare practitioners—providing a trusted, practice-based perspective to support personalized medical care.

Copeia In Partnership with

Please use laptop/computer for optimal display

Copeia In Partnership with

Sharing Real-World Cannabis Therapy Insights: German Experience for a Global Medical Community – In Collaboration with Aurora

Developed by Copeia and initially launched in Germany, PEP EN is the international, English-language edition of the Physicians Experience Platform (PEP). In partnership with Aurora, PEP EN offers healthcare professionals worldwide access to curated case studies based on real-world experiences with cannabis-based therapies.

PEP offers medical professionals easy and free access to a platform that presents physician experiences through structured case reports. Cannabis-based medicines are used in chronically ill patients with a wide range of indications. Within these indications, both pharmacological and non-pharmacological therapies are typically employed to treat the underlying condition and its accompanying symptoms.

As a non-causal form of therapy, cannabis-based medicines primarily target the management of accompanying symptoms that significantly impact patients’ quality of life.

By capturing information on the treatment of individual symptoms, specific cannabis-based medicines used, concurrent medications, dosages, and any side effects, PEP offers a structured approach to evaluating individualized medical cannabis therapy.

The four Pillars of a PEP Case

1

2

3

4

Medical history of anonymized patients
Treated symptoms, their progression, and therapy summary
Documentation of pharmacological and non-pharmacological therapies before and during CAM treatment
Cannabis-based medicines (CAM) used, dosage, and documentation of side effects

See five PEP Reference Cases

Please Note: Some content is blurred due to sensitive medical information. To gain full access, please register and verify your professional status via DocCheck.

Search and Compare Case Reports

PEP EN enables the comparison of clinical aspects and treatment outcomes across different cases. By accessing a comprehensive database, physicians’ experiences become visible. This real-world evidence provides a systematic presentation of practice-oriented information.

The structured documentation of individual patient cases supports efficient communication and collaboration—allowing you to share cases with colleagues or to integrate them into your presentations and lectures via downloads of optimized case card pdfs.

We use DocCheck for access to PEP to ensure that the platform remains compliant with regulatory requirements for handling sensitive medical information.

*DocCheck Login required. Info

PEP at a Glance: Comprehensive Insights into Medical Cannabis Therapies

The PEP Explorer enables visual analysis and interpretation of data related to medical cannabis therapy. With interactive features such as the sunburst diagram, users can easily navigate complex information. This user-friendly interface supports the exploration and understanding of current PEP case reports.

Trusted Scientific Review for Evidence-Based Care

PEP by Copeia is supported by the scientific expertise of Prof. Dr. med. Thomas Herdegen, former Deputy Director of the Institute of Experimental and Clinical Pharmacology at the University Medical Center Schleswig-Holstein, and André Ihlenfeld, anesthesiologist, pain specialist, and Medical Director at Copeia.

This team ensures that the platform meets the highest standards of validity and quality. Data is regularly reviewed and validated to ensure compliance with scientific standards. This includes verification of documented patient cases, analysis of treatment courses and outcomes, as well as evaluation of reported side effects and dosages.

With PEP by Copeia, healthcare professionals have access to a trusted resource for real-world insights into cannabis-based therapies—supporting informed clinical decisions and optimal patient care.

At Copeia, we develop digital healthcare solutions to support cannabis-based therapy to drive improvements in personalized treatment that result in better health outcomes. We believe that the future of healthcare lies in radical collaboration that transcends boundaries.

Copeia empowers those who envision a smarter, more connected approach to personal health. Our applications are trusted by patients and healthcare professionals across Germany and are validated through peer-reviewed scientific publications.

→ More Information

Aurora is a global leader in the cannabis industry, serving both the medical and consumer markets worldwide. Dedicated to helping people improve their lives, Aurora is driven by science and innovation, with a focus on delivering premium medical cannabis products.

Aurora’s global manufacturing network includes leading facilities in Canada and Europe, with a focus on meeting the highest domestic and global standards for cannabis cultivation. The company’s portfolio of brands includes Aurora, MedReleaf, Greybeard and Whistler Medical Marijuana Company, among international brands IndiMed and Pedanios. Aurora is committed to opening the world to cannabis, which is made possible by the company’s strength in science and dedicated team.

With a continuous investment in scientific excellence, Aurora is committed to expanding the frontiers of cannabis research and product development. By leading the way in breeding and genetics research, Aurora’s science and innovation team is building a sustainable pipeline of new genetics with innovative traits that will transform the way the world uses cannabis. Aurora’s scientific focus also extends through to medical research and education, exemplified by Aurora’s support of the Physician Experience Platform that will assist healthcare professionals in prescribing medical cannabis.

→ More Information